Figures computed from official regulatory filings — .
Ownershipinsiders 0.73% · institutions 9.35% · short 2.4% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Polyrizon Ltd. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
6 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Izraeli Tomer | Sell | $5.9K | SEC | ||
| Carmel Liron |
| Sell |
| $11.6K |
| SEC |
| Adler Oz | Sell | $39.7K | SEC |
| Izraeli Tomer | Sell | $42.5K | SEC |
| Turgeman Tidhar | Sell | $31.8K | SEC |
| Carmel Liron | Sell | $1.1K | SEC |